ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Nashville, TN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Post-Acute COVID-19 Syndrome
Human Influenza
Pneumonia
Syndrome

COVID-19 trials near Nashville, TN, USA:

A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19 (NextCOVE)

The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...

Active, not recruiting
COVID-19
Biological: mRNA-1283.222
Biological: mRNA-1273.815

Phase 3

Moderna
Moderna

Nashville, Tennessee, United States and 217 other locations

The Primary objective of this study is to determine, using unblinded samples, if it is possible to develop an algorithm for the classification of spe...

Enrolling
Long COVID
Diagnostic Test: RNA Biomarker Blood Test
MaxWell Clinic, PLC

Brentwood, Tennessee, United States and 1 other location

This is a phase 2 double-blind, randomized study of PBI-0451(Pomotrelvir) in nonhospitalized symptomatic adults with COVID-19. PBI--...

Active, not recruiting
COVID-19
Drug: Placebo
Drug: PBI-0451 (Pomotrelvir)

Phase 2

Pardes Biosciences

Franklin, Tennessee, United States of America and 54 other locations

This study is an adaptive, randomized, double blind, platform trial evaluating promising investigational products (IP) for safety and efficacy as ear...

Enrolling
SARS-CoV-2
Drug: Upamostat
Drug: Placebo (PO)

Phase 2

Henry M. Jackson Foundation for the Advancement of Military Medicine

Nashville, Tennessee, United States and 5 other locations

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Nashville, Tennessee, United States and 59 other locations

for teenagers. The booster targets a particular variant of COVID-19, Omicron XBB.1.5. The main focus is on safety: researchers want-...

Active, not recruiting
COVID-19
Biological: Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
Biological: NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine

Phase 3

Novavax
Novavax

Nashville, Tennessee, United States and 19 other locations

studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...

Enrolling
COVID-19
SARS-CoV-2 Virus
Biological: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 10 microgram dose
Biological: Variant-adapted BNT162b2 (Omicron XBB.1.5) 3 microgram dose

Phase 2, Phase 3

BioNTech
BioNTech

Nashville, Tennessee, United States and 114 other locations

This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...

Active, not recruiting
COVID-19
Other: Placebo
Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Open Label Crossover Vaccination period)

Phase 2, Phase 3

Novavax
Novavax

Nashville, Tennessee, United States and 95 other locations

doses of IgPro20 in participants with post SARS-CoV-2 infection 2019 postural orthostatic tachycardia syndrome (post-Coronavirus Disease 2019 \[COVID...

Enrolling
Post-COVID Postural Orthostatic Tachycardia Syndrome
Biological: IgPro20
Biological: Placebo

Phase 3

CSL Behring
CSL Behring

Nashville, Tennessee, United States and 27 other locations

The study is divided into 2 parts: Part 1 and Part 2. The purpose of Part 1 of this study is to generate sufficient safety, reactogenicity, and immun...

Active, not recruiting
Influenza
SARS-CoV-2
Biological: COVID-19 Vaccine 2
Biological: Investigational COVID-19 Vaccine 1

Phase 1, Phase 2

Moderna
Moderna

Hendersonville, Tennessee, United States and 68 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems